Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 39 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
381 19.5 months metastatic colorectal cancer 5 Chemotherapy
University General Hospital of Heraklion Greece 2/2006
Treatment Details: Patients: This Phase III study involved 285 patients with metastatic colorectal cancer. The patients were randomly divided into two groups. Group A had 146 patients (82 men, 61 women) with
 
382 19.5 months Bladder 5 Chemotherapy
Fondazione IRCCS Istituto Nazionale dei Tumori Italy 6/2014
Treatment Details: Patients: This study involved 157 metastatic urothelial cancer patients with a median age of 60 years. No gender information was provided. Treatment: Patients were treated with the che
 
383 19.5 months NHL 3 Chemotherapy
Shandong Cancer Hospital China 7/2015
Treatment Details: Patients: This study involved 12 elderly primary central nervous system lymphoma patients. The median patient age was 73.9 years (range of 65-84 years) and 9 were male. Treatment: Pati
 
384 19.4 months Malignant Pleural Mesothelioma 4 Chemotherapy
Hyogo College of Medicine Japan 7/2013
Treatment Details: Patients: This study involved 21 malignant pleural mesothelioma patients. The median patient age was 63 years and 76.2% were male. Treatment: Patients received the chemotherapy agents
 
385 19.4 months NSCLC 5 Biologic therapy
Chemotherapy
Radiation
University of Texas Health Science Center United States 9/2013
Treatment Details: Patients: This phase 2 study involved 40 non-small-cell lung cancer patients with a median age of 67 years; 65% were male. Treatment: Patients were treated with radiation therapy, chemo
 
386 19.4 months Hormone-refractory metastatic prostate cancer 4 Chemotherapy
Kumamoto University Japan 1/2008
Treatment Details: Patients: This study involved 34 men with hormone-refractory metastatic prostate cancer. The median patient age was 72.3 years. Treatment: Patients were treated with the chemotherapy a
 
387 19.4 months Recurrent ovarian cancer 4 Chemotherapy
Charité University Hospital, Campus Virchow-Clinic Germany 8/2008
Treatment Details: Patients: This phase I/II study involved 26 women with platinum-sensitive recurrent ovarian cancer. Their median age was 62, ranging from 28 to 75 years of age. Treatment: Patients wer
 
388 19.4 months Metastatic breast cancer 4 Biologic therapy
Albert Einstein College of Medicine United States 4/2009
Treatment Details: Patients: This phase 2 study involved 33 women with metastatic or surgically incurable advanced breast cancer. They were all post-menopausal. The median age was 61 years, ranging from 39
 
389 19.4 months Metastatic, castration-resistant prostate cancer 4 Chemotherapy
The Cancer Institute of New Jersey, UMDNJ-RWJMS United States 2/2010
Treatment Details: Patients: This phase II trial involved 63 men with metastatic castration-resistant prostate cancer that were separated into 2 separate studies (arms). Arm A involved 32 of the men with a m
 
390 19.4 months Metastatic, castration-resistant prostate cancer 4 Chemotherapy
Cleveland Clinic Taussig Cancer Institute United States 10/2010
Treatment Details: Patients: This phase 2 trial involved 35 male metastatic castration-resistant prostate cancer patients with a median age of 67 years and a range of 55-84. Treatment: Patients in this st
 
Page 39 of 187  | Previous Page  | Next Page